Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2008

Open Access 01-03-2008 | Healthcare Policy and Outcomes

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

Authors: Karl Y. Bilimoria, MD, Andrew K. Stewart, MA, David P. Winchester, MD, Clifford Y. Ko, MD, MS, MSHS

Published in: Annals of Surgical Oncology | Issue 3/2008

Login to get access

Excerpt

The National Cancer Data Base (NCDB) is a nationwide oncology outcomes database that currently collects information on approximately 70% of all new invasive cancer diagnoses in the United States each year and serves as a powerful clinical surveillance and quality improvement mechanism for cancer programs participating in the American College of Surgeons (ACoS) Commission on Cancer (CoC) approvals program.1‐3 Currently, the NCDB receives over one million cancer case reports annually from more than 1,430 hospitals. The NCDB now contains data on more than 21 million cancer patients diagnosed between 1985 and 2005, and is recognized as the largest clinical registry in the world. NCDB data are used to explore trends in cancer care, to examine regional and national benchmarks, and to serve as the basis for quality improvement activities (http://​www.​facs.​org/​cancer/​ncdb) …
Literature
1.
2.
3.
Winchester DP, Stewart AK, Bura C, et al. The National Cancer Data Base: A clinical surveillance and quality improvement tool. J Surg Oncol 2004;85:1–3PubMedCrossRef
4.
5.
6.
Cancer Registries Amendment Act, Public Law 102–515. Congressional Record 1992; 138, 106 STAT 3372–7
7.
Facility Oncology Registry Data Standards. Chicago: Commission on Cancer; 2004
8.
9.
10.
11.
12.
13.
A. K. Stewart, E. G. Gay, L. Patel-Parekh, et al. Provider feedback improves reporting on quality measures: National profile reports for adjuvant chemotherapy for stage III colon cancer. Presented at the American Society of Clincal Oncology Annual Meeting, Chicago, 2007
14.
15.
Sylvester M, Blankenship C, Carter A, et al. Quality control: The American College of Surgeons Commission on Cancer Standards, National Cancer Data Base, and Cancer Liason Program. J Reg Mgmt 2001;28:68–74
16.
Eberle C, Phillips J, Tary P, et al. Quality management in the National Cancer Data Base: A re-abstracting study of the Midwest region. J Reg Mgmt 1997;24:93–7
17.
Fremgen A, Jessup J, Menck HR. Hospital use of NCDB data to assess quality of cancer patient care. J Reg Mgmt 1995;22:69–71
18.
Mulnar K, Phillips J, Fritz A, et al. Quality of oncology data: Findings from the Commission on Cancer PCE study. J Reg Mgmt 2001;28:24–34
19.
Standards for Cancer Registries. Data Standards and Data Dictionary, 8th Ed., Version 10.1, Vol. II. Springfield, IL: North American Association of Central Cancer Registries; 2003
20.
International Classification of Disease for Oncology, 3rd ed. Geneva: World Health Organization; 2000
21.
AJCC Cancer Staging Manual. 6th ed. Chicago, IL: Springer; 2002
22.
Health Insurance Portability and Accountability Act (HIPAA), 1996. Standards for Privacy of Individually Identifiable Health Information; Final Rule (45 CFR Parts 160 and 164)
23.
24.
Bilimoria KY, Tomlinson JS, Merkow RP, et al. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg 2007;11:1460–9PubMedCrossRef
25.
Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery 2007; 142(6):906–13PubMedCrossRef
26.
Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. J Am Med Assoc 2005;294:2703–11CrossRef
27.
You YN, Baxter NN, Stewart A, et al. Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg 2007;245:726–33PubMedCrossRef
28.
David KA, Milowsky MI, Ritchey J, et al. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: A report from the National Cancer Data Base. J Urol 2007;178:451–4PubMedCrossRef
29.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Multimodality therapy for pancreatic cancer in the U.S.: Utilization, outcomes, and the effect of hospital volume. Cancer 2007;110:1227–34PubMedCrossRef
30.
Kennedy T, Stewart AK, Bilimoria KY, et al. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients. Ann Surg Oncol 2007;14:2918–27PubMedCrossRef
31.
Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: Changes in demographics, patterns of care, and survival. Laryngoscope 2006;116:S1–13CrossRef
32.
Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: A report from the National Cancer Data Base. Ann Surg 2005;242:281–9PubMedCrossRef
33.
Bilimoria KY, Talamonti M, Tomlinson JS, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: Analysis of 3,851 patients. Ann Surg 2007; in press
34.
Pezzi CM, Patel-Parekh L, Cole K, et al. Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol 2007;14:166–73PubMedCrossRef
35.
Lange JR, Palis BE, Chang DC, et al. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol 2007;25:1363–8PubMedCrossRef
36.
Zhen W, Karnell LH, Hoffman HT, et al. The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck 2004;26:660–74PubMedCrossRef
37.
Smith RB, Apostolakis LW, Karnell LH, et al. National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 2003;98:1670–80PubMedCrossRef
38.
Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002; 94:730–7PubMedCrossRef
39.
Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg 2007;246:173–80PubMedCrossRef
40.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer 2007;110:738–44PubMedCrossRef
41.
Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003;10:65–71PubMedCrossRef
42.
Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: Changing cancer staging by analysis of data from the National Cancer Database. Ann Surg 2006;243:767–71; discussion 771–4PubMedCrossRef
43.
Bilimoria K, Bentrem DJ, Merkow R, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg 2007; in press
44.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Validation of the 6(th) edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer 2007;110:738–44PubMedCrossRef
45.
Greene FL. TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol 2003;21:23–9PubMedCrossRef
46.
Greene FL, Stewart AK, Norton HJ. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: An analysis. J Clin Oncol 2004;22:1778–84PubMedCrossRef
47.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375–384PubMedCrossRef
48.
Bilimoria K, Stewart A, Palis B, et al. Adequacy and importance of nodal examination for colon cancer in the elderly. J Am Coll Surg 2007
49.
Bilimoria K, Talamonti MS, Ko C, et al. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Western Surgical Association Annual Meeting, Colorado Springs, Colorado, 2007
50.
Reid-Lombardo KM, Gay G, Patel-Parekh L, et al. Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from the National Cancer Data Base. J Gastrointest Surg 2007;11:410–9; discussion 419–20PubMedCrossRef
51.
Malin JL, Kahn KL, Adams J, et al. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 2002;94:835–44PubMed
52.
Halpern MT, Bian J, Ward EM, et al. Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer 2007;110:403–11PubMedCrossRef
53.
Shin SH, Palis BE, Perry RR. Cutaneous Melanoma in Asian Americans. Society of Surgical Oncology 2007 Annual Meeting, Washington, DC, 2007
54.
McGinnis LS, Menck HR, Eyre HJ, et al. National Cancer Data Base survey of breast cancer management for patients from low income zip codes. Cancer 2000;88:933–45PubMedCrossRef
55.
Newman LA, Lee CT, Parekh LP, et al. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer 2006;106:188–95PubMedCrossRef
56.
Bilimoria KY, Stewart A, Tomlinson JS, et al. Impact of adjuvant radiation on survival: A note of caution when using cancer registry data to evaluate adjuvant treatments. Ann Surg Oncol 2007; in press
57.
Miller DC, Spencer BA, Ritchey J, et al. Treatment choice and quality of care for men with localized prostate cancer. Med Care 2007;45:401–9PubMedCrossRef
58.
Warren JL, Harlan LC. Can cancer registry data be used to study cancer treatment? Med Care 2003;41(9):1003–5PubMedCrossRef
59.
Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375–81, discussion 381–4PubMedCrossRef
60.
61.
62.
63.
Metadata
Title
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
Authors
Karl Y. Bilimoria, MD
Andrew K. Stewart, MA
David P. Winchester, MD
Clifford Y. Ko, MD, MS, MSHS
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9747-3

Other articles of this Issue 3/2008

Annals of Surgical Oncology 3/2008 Go to the issue

Breast Oncology

S-Classification of Sentinel Lymph Node Predicts Axillary Nonsentinel Lymph Node Status in Patients with Breast Cancer

Breast Oncology

Atypical Ductal Hyperplasia at Margin of Breast Biopsy—Is Re-Excision Indicated?

Gastrointestinal Oncology

Factors Influencing Pathologic Results after Total Mesorectal Excision for Rectal Cancer: Analysis of Consecutive 100 Cases

Gastrointestinal Oncology

Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis

Laboratory Research

Confirmation of Sentinel Lymph Node Identity by Analysis of Fine-Needle Biopsy Samples Using Inductively Coupled Plasma–Mass Spectrometry

Gastrointestinal Oncology

Aggressive Surgical Management of Peritoneal Carcinomatosis With Low Mortality in a High-Volume Tertiary Cancer Center